Seamless Therapeutics Announces New CEO and Board Chairman to Support US Expansion of Programmable Recombinase Gene Editing Technology Platform [Yahoo! Finance]
Q32 Bio Inc. (QTTB)
Company Research
Source: Yahoo! Finance
-- Seamless to develop programmable recombinases focused on precise, large edits targeting diseases of significant unmet medical need -- DRESDEN, Germany & LEXINGTON, Mass., April 23, 2024 BUSINESS WIRE Seamless Therapeutics today announced the appointments of Albert Seymour, Ph.D., as its new President and Chief Executive Officer and Adam Rosenberg as Independent Chairman of the company's Board of Directors. Both bring longstanding track records of successfully leading trailblazing biotechnology companies with an emphasis on gene editing and novel technologies. In addition, their combined experience will be instrumental in establishing Seamless Therapeutics' Research and Development (R&D) activities in the US. In conjunction with the leadership additions, Seamless Tx Inc. will be established in Lexington, MA to focus on the translation of the differentiated recombinase technology from early discovery into the clinic. Dr. Seymour will be based in this office and replace Acting CEO
Show less
Read more
Impact Snapshot
Event Time:
QTTB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTTB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTTB alerts
High impacting Q32 Bio Inc. news events
Weekly update
A roundup of the hottest topics
QTTB
News
- Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- Q32 Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdatePR Newswire
- Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer [Yahoo! Finance]Yahoo! Finance
- Q32 Bio Inc. (NASDAQ: QTTB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $50.00 price target on the stock.MarketBeat
- Q32 Bio Appoints Lee Kalowski as President & Chief Financial OfficerPR Newswire
QTTB
Earnings
- 5/9/24 - Miss
QTTB
Sec Filings
- 5/13/24 - Form SC
- 5/9/24 - Form 424B3
- 5/9/24 - Form 10-Q
- QTTB's page on the SEC website